Bicycle Therapeutics (BCYC) Debt to Equity (2020 - 2024)
Historic Debt to Equity for Bicycle Therapeutics (BCYC) over the last 5 years, with Q2 2024 value amounting to $0.04.
- Bicycle Therapeutics' Debt to Equity fell 7448.5% to $0.04 in Q2 2024 from the same period last year, while for Jun 2024 it was $0.04, marking a year-over-year decrease of 7448.5%. This contributed to the annual value of $0.08 for FY2023, which is 2607.7% down from last year.
- Bicycle Therapeutics' Debt to Equity amounted to $0.04 in Q2 2024, which was down 7448.5% from $0.09 recorded in Q1 2024.
- Bicycle Therapeutics' 5-year Debt to Equity high stood at $0.21 for Q2 2021, and its period low was $0.04 during Q2 2024.
- Its 5-year average for Debt to Equity is $0.12, with a median of $0.11 in 2022.
- As far as peak fluctuations go, Bicycle Therapeutics' Debt to Equity soared by 4321.13% in 2023, and later plummeted by 7448.5% in 2024.
- Over the past 5 years, Bicycle Therapeutics' Debt to Equity (Quarter) stood at $0.15 in 2020, then tumbled by 43.22% to $0.09 in 2021, then rose by 29.76% to $0.11 in 2022, then dropped by 26.08% to $0.08 in 2023, then crashed by 57.26% to $0.04 in 2024.
- Its last three reported values are $0.04 in Q2 2024, $0.09 for Q1 2024, and $0.08 during Q4 2023.